Last reviewed · How we verify

NCT05159505

Interdisciplinary Scoliosis Correction Program.

Status unknown Last updated 16 December 2021
What this trial tests

trial in Scoliosis Idiopathic in 120 participants. Status unknown.

Timeline
1 December 2021
Primary endpoint
30 June 2022
30 September 2022

Quick facts

Lead sponsorPomeranian Medical University Szczecin
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment120
Start date1 December 2021
Primary completion30 June 2022
Estimated completion30 September 2022
Sites1 location across Poland

Conditions studied

Sponsor

Pomeranian Medical University Szczecin

Who can join

Adults 10 to 18, any sex, with Scoliosis Idiopathic or Scoliosis; Juvenile. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the outcomes after scoliosis surgery before and after the implementation of an interdisciplinary juvenile scoliosis correction program in teenager based on ERAS (enhanced recovery after surgery) principles.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Scoliosis Idiopathic

Currently open trials in the same condition.

Other Pomeranian Medical University Szczecin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05159505.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing